3FDA. FDA Drug Safety Communication: New contraindication andupdated warning on kidney impairment for Reclast ( zoledronicacid)[EB/OL]. (2011-09-01) [2015-05-11 ]. http//www. fda.gov/Drugs/DrugSafety/ucm270199. htm.
5Miyata T,Oda 0,Inaqi R,et al. p2-microglobulon mocdified withadvanced glyeation and products is a major component of hemodialysisassociated amylodosis[J]. J Clin Invest, 1993, 92(3) : 1243-1252.